Follow-The-Filings

Security · featured owners

BCAX Bicara Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 2.3%
  • $25M
  • 1 reduce

BCAX (Bicara Therapeutics Inc.) is held in 2 featured 13F books as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (2.3%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.3% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 2.3%
  2. Nathan Fischel reduce 1.6%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 2.3% Hold 550,408 $16M history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.6% Reduce −32.4% 284,955 $8M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 10, 2026 · 3 forms Filing Doc
4 Period Jul 28, 2026 · 2 forms Filing Doc
4 Period Jul 10, 2026 Filing Doc
4 Period Jul 8, 2026 · 2 forms Filing Doc
4 Period Jun 9, 2026 · 7 forms Filing Doc
4 Period May 21, 2026 Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period May 8, 2026 Filing Doc
4 Period Apr 27, 2026 Filing Doc
4 Period Apr 21, 2026 Filing Doc
4 Period Apr 16, 2026 Filing Doc
4 Period Apr 15, 2026 Filing Doc

Updated about 23 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Net income -$68M -$137.95M

Balance sheet

Metric FY2024 FY2025
Total current assets $502.53M $422.05M
Total non-current assets * $7.46M $8.94M
Total assets $510M $430.99M
Total current liabilities $17.99M $28.95M
Total non-current liabilities * $131,000 $593,000
Total equity $491.88M $401.45M

Cash flow

Metric FY2024 FY2025
Cash from operations -$74.75M -$106.83M
Cash from investing -$0.009M -$318.45M
Cash from financing $334.03M $32.26M
Net change in cash $259.27M -$393.03M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders